- Home
- STAA vs MGNI Comparison
STAA vs MGNI Comparison
Compare STAA & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- MGNI
- Stock Information
- Founded
- STAA 1982
- MGNI 2007
- Country
- STAA United States
- MGNI United States
- Employees
- STAA N/A
- MGNI N/A
- Industry
- STAA Ophthalmic Goods
- MGNI Computer Software: Programming Data Processing
- Sector
- STAA Health Care
- MGNI Technology
- Exchange
- STAA Nasdaq
- MGNI Nasdaq
- Market Cap
- STAA 2.0B
- MGNI 1.7B
- IPO Year
- STAA N/A
- MGNI N/A
- Fundamental
- Price
- STAA $30.20
- MGNI $12.94
- Analyst Decision
- STAA Buy
- MGNI Strong Buy
- Analyst Count
- STAA 7
- MGNI 11
- Target Price
- STAA $45.00
- MGNI $16.95
- AVG Volume (30 Days)
- STAA 605.4K
- MGNI 1.3M
- Earning Date
- STAA 10-30-2024
- MGNI 11-07-2024
- Dividend Yield
- STAA N/A
- MGNI N/A
- EPS Growth
- STAA N/A
- MGNI N/A
- EPS
- STAA 0.33
- MGNI N/A
- Revenue
- STAA $332,942,000.00
- MGNI $649,216,000.00
- Revenue This Year
- STAA $8.76
- MGNI $0.26
- Revenue Next Year
- STAA $14.28
- MGNI $10.75
- P/E Ratio
- STAA $91.84
- MGNI N/A
- Revenue Growth
- STAA 8.83
- MGNI 7.50
- 52 Week Low
- STAA $26.66
- MGNI $6.46
- 52 Week High
- STAA $52.68
- MGNI $15.92
- Technical
- Relative Strength Index (RSI)
- STAA 41.25
- MGNI 54.59
- Support Level
- STAA $29.91
- MGNI $12.35
- Resistance Level
- STAA $31.41
- MGNI $13.11
- Average True Range (ATR)
- STAA 1.07
- MGNI 0.42
- MACD
- STAA -0.08
- MGNI 0.11
- Stochastic Oscillator
- STAA 15.56
- MGNI 63.58
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
About MGNI Magnite Inc.
Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.